Spatial multiomics atlas reveals new insights into kidney transplant injury

Kidney transplantation offers an important treatment option for patients with end-stage kidney disease. However, long-term graft survival remains a major challenge. Chronic allograft dysfunction (CAD) is an important contributor to poor long-term outcomes, with renal interstitial fibrosis recognized as one of its key pathological features.

Fibrosis is not simply the accumulation of scar tissue. It is a complex process involving multiple cell types and their interactions. Do different regions of the kidney undergo fibrosis through distinct mechanisms? How are immune cells, tubular epithelial cells, and metabolic changes connected during this process? These questions remain incompletely understood.

To investigate chronic kidney allograft injury, the research team established a tacrolimus-modulated mouse model of chronic allograft dysfunction. They integrated several types of data, including mouse single-cell RNA sequencing, flow cytometry, and multiplex imaging, together with human single-nucleus RNA sequencing, spatial transcriptomics, and spatial metabolomics from kidney transplant samples.

By combining cross-species analysis with spatial and metabolic information, the researchers linked cellular characteristics to their locations and molecular features within kidney tissue. This approach enabled them to construct a spatial multiomics atlas of chronic allograft injury and examine fibrosis from multiple perspectives.

The study revealed that fibrosis in different kidney regions is associated with distinct cellular and metabolic features.

In the renal cortex, fibrosis was associated with remodeling of endothelial cells and pericytes. These changes were accompanied by alterations in cholesterol-biosynthesis-related gene expression programs and reduced regional cholesterol-related signals.

In the renal medulla, proximal tubule S3 (PT(S3)) cells showed glycolysis-associated features, alongside increased regional lactate-related signals. Nearby, tissue-resident memory T-cell populations displayed an atypical exhaustion-like transcriptional program.

The researchers also conducted cell experiments and found that the glycolysis inhibitor 2-deoxy-D-glucose (2-DG) partially attenuated TGF-β1-induced changes in renal tubular epithelial cells. This provided preliminary experimental support for a link between glycolysis and tubular cell-state changes.

This study suggests that fibrosis during chronic kidney allograft injury is not a uniform process. Instead, different kidney regions may exhibit distinct cellular compositions and metabolic characteristics. The cross-species spatial multiomics atlas also provides a resource for further investigating the relationships among immunity, metabolism, and tissue fibrosis.

Importantly, some of the findings are based on associations identified through omics analyses and do not establish causal relationships between specific cellular changes, metabolic pathways, and fibrosis. Further studies involving larger human cohorts, lineage-tracing approaches, and targeted interventions will be needed to validate these potential mechanisms.

Overall, this work provides a spatial perspective on regional differences in chronic kidney allograft injury and offers clues for identifying potential targets for future investigation.

Source:
Journal reference:

Gao, Q., et al. (2026). A spatial multiomics atlas and resource for immune-fibrotic niches in chronic kidney allograft dysfunction. Cyborg and Bionic Systems. DOI: 10.34133/cbsystems.0720. https://spj.science.org/doi/10.34133/cbsystems.0720

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mount Sinai wins $4 million NIH grant to improve prediction of postoperative acute kidney injury